Healthcare & Pharmaceuticals

Top News

Pfizer's hemophilia therapy reduces bleeding in late-stage study
Future of Healthcategory

U.S. drugmaker Pfizer Inc said on Tuesday late-stage study data for its experimental hemophilia therapy showed superiority to the current standard of care treatment in reducing bleeding rates in patients.

Reuters Events Logo

Talking Points

Latest Stories